We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and COVID-19: Demonstrating the Actionability of Real-World Evidence.
- Authors
Hennessy, Sean; Cohen, Jordana B
- Abstract
Use of renin-angiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study. 13 These data prompted the initiation of several randomized controlled trials that are currently underway evaluating ACEIs, ARBs, and recombinant ACE2 as potential therapies for COVID-19.
- Subjects
ANGIOTENSIN-receptor blockers; COVID-19; ACE inhibitors; ANGIOTENSIN receptors; COVID-19 pandemic
- Publication
American Journal of Hypertension, 2021, Vol 34, Issue 4, p327
- ISSN
0895-7061
- Publication type
Article
- DOI
10.1093/ajh/hpaa177